SlideShare a Scribd company logo
1 of 3
Christopher Brawley
1017 W. Hamilton Ave. Apt. 2 Campbell CA 95008
T 408 930-9475
cbrawley@gmail.com
EXPERIENCE
Clinical Trial Manager, Natera Inc.
San Carlos, CA- June 2016 – Present
 Responsible for the implementation of large volume clinical trials activities per study protocol.
 Works closely with investigative sitepersonnel, CROs, and other study vendors to ensure protocolexecution
 Managed study contracting, budget and payment process for all clinical trial vendors including investigational sites
 Designed study related documents and templates, including but not limited to study protocol, informed consent forms,
CRFs, and regulatory binders
 Responsible for siteselection and initiation
 Trained CROs, vendors, investigators and study coordinators on study protocoland relevant requirements
 Monitor and track clinical trial progress and provide status updateto stakeholders, through the creation of study
progress dashboards, and other tracking metrics
 Created Clinical Study Report templatefor Natera, Inc
Senior Clinical Trial Management Associate Hematology/Oncology, Gilead Sciences;
Foster City, CA- February 2016- June 2016
 Assisted in the development and planning of investigator meeting agenda and content.
 Developed materials and training slides for use at investigator meeting
 Presented protocolspecific training at investigator meeting for both general and breakout sessions
 Created dashboard metric slides to provide transparency amongst both internal and external members of our study
team.
 Assisted in the development and updating of study timelines
 Participated in departmentalor interdepartmental strategic initiatives under general supervision
 Participated and effectively ran meetings and conference calls with CROs, vendors, and multi-functional teams
 Developed new study specific training materials for use at both thesite and CRO level
 Anticipateobstacles and proactively develop solutions to achieve project goals
 Interfaced with individuals in other functional areas to address routine study issues through study management team
meetings
 Assisted in the training of CTMAs and CPAs
 Reviewed of routine data and preparation of safety, interim, and final study reports, and resolution of data discrepancies
Clinical Trial Management Associate Hematology/Oncology, Gilead Sciences;
Foster City, CA- August 2014 –February 2016
 Developed a cross functional process, using an existing internal database, to automate appendices required from
Clinical Operations for thefinal CSR (awarded 2015 innovation award for clinical operations)
 Independently managed study vendors and scope of work changes for two global hematology/oncology phase2 clinical
trials
 Documented and escalated serious vendor issues affecting our study to share with our company as a whole to prevent
future occurrences.
 Led cross functional development and execution of protocolamendments, and proactively requested feedback on future
protocols in development to ensure all necessary changes were implemented
 Performed monthly review of vendor budget variance reports and unprocessed site payment reports consolidating
invoices across data obtained from multiple data platforms
 Developed of site facing documents to address laboratory processing issues surrounding critical central lab values for
safety analysis
 Developed strategy and scenario build for UAT testing for study vendors.
 Participated in and UAT testing for vendors prior to study startup.
 Assisted in the development of study dataquality review plan to outline review process.
 Established study specific Trial Master File plans to allow for use of a central TMF as well as an off-site CRO TMF
 Performed routine TMF reviews on both central files and off-sitefiles
 Assembled and delivered Clinical Operations sections for CSR publication.
 Participatein routine data line listing review to support preparation of safety, interim and final study reports
 Developed and delivered protocolamendment training to study vendors and clinical research organization.
 Identified and resolved an internal systemautomated error surrounding assigned visit cost and updated protocolnaming
convention resulting in sites not receiving proper reimbursement for study visit
 Authored study newsletters to address study sites on pertinent study information on an regular basis
 Ensured proper escalation regarding important protocoldeviations that occur throughout the study as well as ensuring
that the appropriateactions have taken place to mitigate any future risk
 Established routine CRO monitoring report reviews to address any issues surrounding monitoring trip or report quality
 Performed essential regulatory document review and approvalprior to site activation
 Facilitated cross functional study management team meetings, providing accurate documentation of decisions reached
and action items assigned
 Recipient of May 2015 Oncology Star Award
 Recipient of peer to peer G-Thanks Award for onboarding of colleagues outsidemy immediate team
Senior Clinical Research Assistant, Stanford University Department of Pediatric Hematology/Oncology;
Stanford, CA- August 2012 – July 2014
 Managed approximately 50 Phase I through IV clinical trials in relapsed leukemia, AML, Hodgkin disease, Non-
Hodgkin Lymphomaand Hepatoblastoma.
 Developed and manage an on-line database to improve communication surrounding research participants between
research assistants, clinicians and local research laboratories.
 Liaised with numerous constituencies within Lucile Packard Children’s Hospitalin analyzing and improving order sets
for chemotherapy.
 Contributed to thedesign and implementation of a Division-wide policy for patients receiving investigational agents
while on a research protocol.
 Developed disease-specific and consent process flowcharts to serve as reference guides for research assistants and
clinicians.
 Contributed to thedevelopment and validation sessions of the EPIC medical record database implementation for
LPCH.
 Assisted in the annual training of new clinical Fellows.
 Oversaw training and on-boarding for newly hired research assistants and evaluate areas to improve our training
process for new employees
 Assisted in the identification and resolution of performance and interpersonal issues among our team.
 Monitored and reported any instances of non-compliance with Stanford, stateor federal policies surrounding clinical
research amongst junior staff.
 Coached junior staff in resolving any issues surrounding the execution of their individual studies.
 Facilitated CRA group discussions in evaluation of potentialCRA candidates throughout interview process.
 Analyzed technical and communication skills of all CRA candidates, and provide recommendations for hiring.
Clinical Research Assistant, Stanford University department of Pediatric Hematology/Oncology; Stanford,
CA- July 2011 – August 2012
 Coordinated Phase I through IV clinical trials in pediatric oncology.
 Contributed in thepre-audit preparation of research material and audit process of our successful 2012 Children’s
Oncology Group audit.
 Organized and implemented routine internal audits of eligibility and data quality.
 Analyzed internal audit findings to recommend improvements in our internal processes.
 Designed, and managed, internal database to supervise group progress for quarterly data deadlines.
 Developed and coordinated an internal process to execute the ATHN hematological database.
 Contributed to routine DataSafety Monitoring Committee audits of research protocols within the Cancer Center.
 Prepared for, and participated in site selection visits, siteinitiation visits, routine sponsor monitoring visits, and study
close out visits.
Clinical ResearchCoordinator, UCSF Multiple Sclerosis Center; San Francisco, CA — July 2010-
July 2011
 Coordinated and implemented the sound research of phasethree clinical trials specializing in the treatment of Multiple
Sclerosis.
 Oversaw scheduling of on and off-site study procedures for upwards of thirty study participants.
 Managed multiple clinical trials from various sponsors and ensure the sound conduct of all research procedures.
 Prepared for and scheduled monthly sponsored monitoring visits.
 Maintained numerous aspects of phasethree trials including: investigational drug storage and management, proper
storage and maintenance of study participant data, and tracking study participant compliancewithin protocol
guidelines.
EDUCATION
 University Of Illinois at Urbana Champaign, BS Molecular Biology, 2007
Awards and Recognition
 Recipient of the 2015 Gilead Clinical Operation Innovation Award for the automation of clinical operations
deliverables for Clinical Study Reports.
 Recipient of May 2015 Oncology Star Award
 Recipient of peer to peer G-Thanks Award for onboarding colleague outside of my immediate team
 Recipient of Values at Work Award 2015
SKILLS
Database creation and design using the Redcap systemfor clinical research
Creating visual reference sheets that help to simplify more complex processes within clinical research
Proficient in medical terminology (including oncology)
Proficiency in Microsoft office suite
Maintaining HIPPA regulatory documents
Laboratory maintenance and inventory
Research specimen management
Obtaining informed consent from study patients
Trial drug dispensation, accountability, storage
CERTIFICATIONS
Data management for clinical researcher statement of accomplishment (Vanderbilt University)
Principles of Good Clinical Research certificate of completion
Oncology Research Forum certificate of completion
CITI Certification
BSL Level 2
REFERENCES
Available upon request

More Related Content

What's hot

Peterson Wanda -CV 12-1-15
Peterson Wanda -CV 12-1-15Peterson Wanda -CV 12-1-15
Peterson Wanda -CV 12-1-15Wanda Peterson
 
062016CV_Johnson_Debra [147732]
062016CV_Johnson_Debra [147732]062016CV_Johnson_Debra [147732]
062016CV_Johnson_Debra [147732]Debra Johnson
 
Toni Brown Resume 2016
Toni Brown Resume 2016Toni Brown Resume 2016
Toni Brown Resume 2016Toni Brown
 
Corey M. Raines Resume
Corey M. Raines ResumeCorey M. Raines Resume
Corey M. Raines ResumeCorey Raines
 
CV_Sandra Frazilus MAY2015
CV_Sandra Frazilus MAY2015CV_Sandra Frazilus MAY2015
CV_Sandra Frazilus MAY2015Sandra Frazilus
 
Deanna Goodwin Mouser
Deanna Goodwin MouserDeanna Goodwin Mouser
Deanna Goodwin MouserDeanna Mouser
 
Highlights from ExL Pharma's Proactive GCP Compliance
Highlights from ExL Pharma's Proactive GCP ComplianceHighlights from ExL Pharma's Proactive GCP Compliance
Highlights from ExL Pharma's Proactive GCP ComplianceExL Pharma
 
The AHRQ Training Modules for the Systematic Reviews Methods Guide: An Introd...
The AHRQ Training Modules for the Systematic Reviews Methods Guide: An Introd...The AHRQ Training Modules for the Systematic Reviews Methods Guide: An Introd...
The AHRQ Training Modules for the Systematic Reviews Methods Guide: An Introd...Effective Health Care Program
 
Demonstrating Clinical Utility
Demonstrating Clinical UtilityDemonstrating Clinical Utility
Demonstrating Clinical UtilityIMARC Research
 
Imaging Endpoints for Clinical Trials by Kenneth G. Faulkner, Ph.D., Corporat...
Imaging Endpoints for Clinical Trials by Kenneth G. Faulkner, Ph.D., Corporat...Imaging Endpoints for Clinical Trials by Kenneth G. Faulkner, Ph.D., Corporat...
Imaging Endpoints for Clinical Trials by Kenneth G. Faulkner, Ph.D., Corporat...PAREXEL International
 
Strategies for Auditors to Prepare Clinical Research Personnel For a Regulato...
Strategies for Auditors to Prepare Clinical Research Personnel For a Regulato...Strategies for Auditors to Prepare Clinical Research Personnel For a Regulato...
Strategies for Auditors to Prepare Clinical Research Personnel For a Regulato...IMARC Research
 
Let 1000 flowers bloom: Support for the current “system”
Let 1000 flowers bloom: Support for the current “system”Let 1000 flowers bloom: Support for the current “system”
Let 1000 flowers bloom: Support for the current “system”Cochrane.Collaboration
 
Centralized vs. Onsite Monitoring
Centralized vs. Onsite MonitoringCentralized vs. Onsite Monitoring
Centralized vs. Onsite MonitoringIMARC Research
 

What's hot (20)

Peterson Wanda -CV 12-1-15
Peterson Wanda -CV 12-1-15Peterson Wanda -CV 12-1-15
Peterson Wanda -CV 12-1-15
 
062016CV_Johnson_Debra [147732]
062016CV_Johnson_Debra [147732]062016CV_Johnson_Debra [147732]
062016CV_Johnson_Debra [147732]
 
PJ_CV_25Sep2015
PJ_CV_25Sep2015PJ_CV_25Sep2015
PJ_CV_25Sep2015
 
Toni Brown Resume 2016
Toni Brown Resume 2016Toni Brown Resume 2016
Toni Brown Resume 2016
 
Corey M. Raines Resume
Corey M. Raines ResumeCorey M. Raines Resume
Corey M. Raines Resume
 
Cra responsebility
Cra responsebilityCra responsebility
Cra responsebility
 
CV_Sandra Frazilus MAY2015
CV_Sandra Frazilus MAY2015CV_Sandra Frazilus MAY2015
CV_Sandra Frazilus MAY2015
 
Strategic Development and Expansion of the Clinical Trials Infrastructure
Strategic Development and Expansion of the Clinical Trials InfrastructureStrategic Development and Expansion of the Clinical Trials Infrastructure
Strategic Development and Expansion of the Clinical Trials Infrastructure
 
Deanna Goodwin Mouser
Deanna Goodwin MouserDeanna Goodwin Mouser
Deanna Goodwin Mouser
 
Cra 1
Cra 1Cra 1
Cra 1
 
Highlights from ExL Pharma's Proactive GCP Compliance
Highlights from ExL Pharma's Proactive GCP ComplianceHighlights from ExL Pharma's Proactive GCP Compliance
Highlights from ExL Pharma's Proactive GCP Compliance
 
Topic Refinement
Topic RefinementTopic Refinement
Topic Refinement
 
The AHRQ Training Modules for the Systematic Reviews Methods Guide: An Introd...
The AHRQ Training Modules for the Systematic Reviews Methods Guide: An Introd...The AHRQ Training Modules for the Systematic Reviews Methods Guide: An Introd...
The AHRQ Training Modules for the Systematic Reviews Methods Guide: An Introd...
 
Demonstrating Clinical Utility
Demonstrating Clinical UtilityDemonstrating Clinical Utility
Demonstrating Clinical Utility
 
Imaging Endpoints for Clinical Trials by Kenneth G. Faulkner, Ph.D., Corporat...
Imaging Endpoints for Clinical Trials by Kenneth G. Faulkner, Ph.D., Corporat...Imaging Endpoints for Clinical Trials by Kenneth G. Faulkner, Ph.D., Corporat...
Imaging Endpoints for Clinical Trials by Kenneth G. Faulkner, Ph.D., Corporat...
 
Strategies for Auditors to Prepare Clinical Research Personnel For a Regulato...
Strategies for Auditors to Prepare Clinical Research Personnel For a Regulato...Strategies for Auditors to Prepare Clinical Research Personnel For a Regulato...
Strategies for Auditors to Prepare Clinical Research Personnel For a Regulato...
 
RISK BASED MONITORING
RISK BASED MONITORINGRISK BASED MONITORING
RISK BASED MONITORING
 
Topic Refinement Quiz
Topic Refinement QuizTopic Refinement Quiz
Topic Refinement Quiz
 
Let 1000 flowers bloom: Support for the current “system”
Let 1000 flowers bloom: Support for the current “system”Let 1000 flowers bloom: Support for the current “system”
Let 1000 flowers bloom: Support for the current “system”
 
Centralized vs. Onsite Monitoring
Centralized vs. Onsite MonitoringCentralized vs. Onsite Monitoring
Centralized vs. Onsite Monitoring
 

Viewers also liked

Phyllanthus in liver dysfunction
Phyllanthus in liver dysfunctionPhyllanthus in liver dysfunction
Phyllanthus in liver dysfunctionabhishek rai
 
Img 20150911 0001
Img 20150911 0001Img 20150911 0001
Img 20150911 0001Flenny Wong
 
Essay question august2015
Essay question august2015Essay question august2015
Essay question august2015Flenny Wong
 
Enbe final project r ev b
Enbe final project r ev bEnbe final project r ev b
Enbe final project r ev bFlenny Wong
 
Course outline august 2015
Course outline august 2015Course outline august 2015
Course outline august 2015Flenny Wong
 
Day 2 session 3 financing and governance v24_october2016 (1)
Day 2 session 3 financing and governance v24_october2016 (1)Day 2 session 3 financing and governance v24_october2016 (1)
Day 2 session 3 financing and governance v24_october2016 (1)mapc88812
 
Day 1 introduction meeting overview_v12_sept2016 (2) (2)
Day 1 introduction meeting overview_v12_sept2016 (2) (2)Day 1 introduction meeting overview_v12_sept2016 (2) (2)
Day 1 introduction meeting overview_v12_sept2016 (2) (2)mapc88812
 
Enbe project one july 2015
Enbe project one    july 2015Enbe project one    july 2015
Enbe project one july 2015Flenny Wong
 
Iciassignment 1b
Iciassignment 1bIciassignment 1b
Iciassignment 1bFlenny Wong
 
Drawing project 1 july 2015_integration (1)
Drawing project 1 july 2015_integration (1)Drawing project 1 july 2015_integration (1)
Drawing project 1 july 2015_integration (1)Flenny Wong
 
Landscape project proposal
Landscape project proposalLandscape project proposal
Landscape project proposalFlenny Wong
 
Day 2 session 3 governance v29_october2016 (mng) new
Day 2 session 3 governance v29_october2016 (mng) newDay 2 session 3 governance v29_october2016 (mng) new
Day 2 session 3 governance v29_october2016 (mng) newmapc88812
 
Day 1 introduction workshop aims_version of 20_october2016 (mng)
Day 1 introduction workshop aims_version of 20_october2016 (mng)Day 1 introduction workshop aims_version of 20_october2016 (mng)
Day 1 introduction workshop aims_version of 20_october2016 (mng)mapc88812
 

Viewers also liked (16)

Phyllanthus in liver dysfunction
Phyllanthus in liver dysfunctionPhyllanthus in liver dysfunction
Phyllanthus in liver dysfunction
 
Edawd
EdawdEdawd
Edawd
 
Img 20150911 0001
Img 20150911 0001Img 20150911 0001
Img 20150911 0001
 
Essay question august2015
Essay question august2015Essay question august2015
Essay question august2015
 
Enbe final project r ev b
Enbe final project r ev bEnbe final project r ev b
Enbe final project r ev b
 
Course outline august 2015
Course outline august 2015Course outline august 2015
Course outline august 2015
 
Day 2 session 3 financing and governance v24_october2016 (1)
Day 2 session 3 financing and governance v24_october2016 (1)Day 2 session 3 financing and governance v24_october2016 (1)
Day 2 session 3 financing and governance v24_october2016 (1)
 
Day 1 introduction meeting overview_v12_sept2016 (2) (2)
Day 1 introduction meeting overview_v12_sept2016 (2) (2)Day 1 introduction meeting overview_v12_sept2016 (2) (2)
Day 1 introduction meeting overview_v12_sept2016 (2) (2)
 
Enbe project one july 2015
Enbe project one    july 2015Enbe project one    july 2015
Enbe project one july 2015
 
Iciassignment 1b
Iciassignment 1bIciassignment 1b
Iciassignment 1b
 
New doc 2
New doc 2New doc 2
New doc 2
 
Drawing project 1 july 2015_integration (1)
Drawing project 1 july 2015_integration (1)Drawing project 1 july 2015_integration (1)
Drawing project 1 july 2015_integration (1)
 
Landscape project proposal
Landscape project proposalLandscape project proposal
Landscape project proposal
 
Magazine
MagazineMagazine
Magazine
 
Day 2 session 3 governance v29_october2016 (mng) new
Day 2 session 3 governance v29_october2016 (mng) newDay 2 session 3 governance v29_october2016 (mng) new
Day 2 session 3 governance v29_october2016 (mng) new
 
Day 1 introduction workshop aims_version of 20_october2016 (mng)
Day 1 introduction workshop aims_version of 20_october2016 (mng)Day 1 introduction workshop aims_version of 20_october2016 (mng)
Day 1 introduction workshop aims_version of 20_october2016 (mng)
 

Similar to Updated 2016 CV

Similar to Updated 2016 CV (20)

Curriculum Vitae Linkedin
Curriculum Vitae LinkedinCurriculum Vitae Linkedin
Curriculum Vitae Linkedin
 
Becker, Lynne resume Mar 2016
Becker, Lynne resume Mar 2016Becker, Lynne resume Mar 2016
Becker, Lynne resume Mar 2016
 
Becker, lynne resume mar2016
Becker, lynne resume mar2016Becker, lynne resume mar2016
Becker, lynne resume mar2016
 
Lori Hall Resume_May2015
Lori Hall  Resume_May2015Lori Hall  Resume_May2015
Lori Hall Resume_May2015
 
Francine_High_CV_07_Jul_2016
Francine_High_CV_07_Jul_2016Francine_High_CV_07_Jul_2016
Francine_High_CV_07_Jul_2016
 
Resume
ResumeResume
Resume
 
Kathleen_Montgomery_Resume_Oct 2015
Kathleen_Montgomery_Resume_Oct 2015Kathleen_Montgomery_Resume_Oct 2015
Kathleen_Montgomery_Resume_Oct 2015
 
CV_Amit Mahendru
CV_Amit MahendruCV_Amit Mahendru
CV_Amit Mahendru
 
Melissa Hamm Resume 2016 Research Only
Melissa Hamm Resume 2016 Research OnlyMelissa Hamm Resume 2016 Research Only
Melissa Hamm Resume 2016 Research Only
 
Melissa Hamm Resume 2016 Research Only
Melissa Hamm Resume 2016 Research OnlyMelissa Hamm Resume 2016 Research Only
Melissa Hamm Resume 2016 Research Only
 
SmithJanisP
SmithJanisPSmithJanisP
SmithJanisP
 
Resume
ResumeResume
Resume
 
CV - CTA 20150926
CV - CTA 20150926CV - CTA 20150926
CV - CTA 20150926
 
Jeremy Fernandez
Jeremy Fernandez Jeremy Fernandez
Jeremy Fernandez
 
Resume
ResumeResume
Resume
 
CV-10.20.15
CV-10.20.15CV-10.20.15
CV-10.20.15
 
Tasso, Vanessa, resume, 6-15
Tasso, Vanessa, resume, 6-15Tasso, Vanessa, resume, 6-15
Tasso, Vanessa, resume, 6-15
 
Resume_SHF_Nov2016
Resume_SHF_Nov2016Resume_SHF_Nov2016
Resume_SHF_Nov2016
 
ABrooks_CV
ABrooks_CVABrooks_CV
ABrooks_CV
 
A brooks cv
A brooks cvA brooks cv
A brooks cv
 

Updated 2016 CV

  • 1. Christopher Brawley 1017 W. Hamilton Ave. Apt. 2 Campbell CA 95008 T 408 930-9475 cbrawley@gmail.com EXPERIENCE Clinical Trial Manager, Natera Inc. San Carlos, CA- June 2016 – Present  Responsible for the implementation of large volume clinical trials activities per study protocol.  Works closely with investigative sitepersonnel, CROs, and other study vendors to ensure protocolexecution  Managed study contracting, budget and payment process for all clinical trial vendors including investigational sites  Designed study related documents and templates, including but not limited to study protocol, informed consent forms, CRFs, and regulatory binders  Responsible for siteselection and initiation  Trained CROs, vendors, investigators and study coordinators on study protocoland relevant requirements  Monitor and track clinical trial progress and provide status updateto stakeholders, through the creation of study progress dashboards, and other tracking metrics  Created Clinical Study Report templatefor Natera, Inc Senior Clinical Trial Management Associate Hematology/Oncology, Gilead Sciences; Foster City, CA- February 2016- June 2016  Assisted in the development and planning of investigator meeting agenda and content.  Developed materials and training slides for use at investigator meeting  Presented protocolspecific training at investigator meeting for both general and breakout sessions  Created dashboard metric slides to provide transparency amongst both internal and external members of our study team.  Assisted in the development and updating of study timelines  Participated in departmentalor interdepartmental strategic initiatives under general supervision  Participated and effectively ran meetings and conference calls with CROs, vendors, and multi-functional teams  Developed new study specific training materials for use at both thesite and CRO level  Anticipateobstacles and proactively develop solutions to achieve project goals  Interfaced with individuals in other functional areas to address routine study issues through study management team meetings  Assisted in the training of CTMAs and CPAs  Reviewed of routine data and preparation of safety, interim, and final study reports, and resolution of data discrepancies Clinical Trial Management Associate Hematology/Oncology, Gilead Sciences; Foster City, CA- August 2014 –February 2016  Developed a cross functional process, using an existing internal database, to automate appendices required from Clinical Operations for thefinal CSR (awarded 2015 innovation award for clinical operations)  Independently managed study vendors and scope of work changes for two global hematology/oncology phase2 clinical trials  Documented and escalated serious vendor issues affecting our study to share with our company as a whole to prevent future occurrences.  Led cross functional development and execution of protocolamendments, and proactively requested feedback on future protocols in development to ensure all necessary changes were implemented  Performed monthly review of vendor budget variance reports and unprocessed site payment reports consolidating invoices across data obtained from multiple data platforms  Developed of site facing documents to address laboratory processing issues surrounding critical central lab values for safety analysis  Developed strategy and scenario build for UAT testing for study vendors.  Participated in and UAT testing for vendors prior to study startup.  Assisted in the development of study dataquality review plan to outline review process.  Established study specific Trial Master File plans to allow for use of a central TMF as well as an off-site CRO TMF  Performed routine TMF reviews on both central files and off-sitefiles  Assembled and delivered Clinical Operations sections for CSR publication.  Participatein routine data line listing review to support preparation of safety, interim and final study reports  Developed and delivered protocolamendment training to study vendors and clinical research organization.
  • 2.  Identified and resolved an internal systemautomated error surrounding assigned visit cost and updated protocolnaming convention resulting in sites not receiving proper reimbursement for study visit  Authored study newsletters to address study sites on pertinent study information on an regular basis  Ensured proper escalation regarding important protocoldeviations that occur throughout the study as well as ensuring that the appropriateactions have taken place to mitigate any future risk  Established routine CRO monitoring report reviews to address any issues surrounding monitoring trip or report quality  Performed essential regulatory document review and approvalprior to site activation  Facilitated cross functional study management team meetings, providing accurate documentation of decisions reached and action items assigned  Recipient of May 2015 Oncology Star Award  Recipient of peer to peer G-Thanks Award for onboarding of colleagues outsidemy immediate team Senior Clinical Research Assistant, Stanford University Department of Pediatric Hematology/Oncology; Stanford, CA- August 2012 – July 2014  Managed approximately 50 Phase I through IV clinical trials in relapsed leukemia, AML, Hodgkin disease, Non- Hodgkin Lymphomaand Hepatoblastoma.  Developed and manage an on-line database to improve communication surrounding research participants between research assistants, clinicians and local research laboratories.  Liaised with numerous constituencies within Lucile Packard Children’s Hospitalin analyzing and improving order sets for chemotherapy.  Contributed to thedesign and implementation of a Division-wide policy for patients receiving investigational agents while on a research protocol.  Developed disease-specific and consent process flowcharts to serve as reference guides for research assistants and clinicians.  Contributed to thedevelopment and validation sessions of the EPIC medical record database implementation for LPCH.  Assisted in the annual training of new clinical Fellows.  Oversaw training and on-boarding for newly hired research assistants and evaluate areas to improve our training process for new employees  Assisted in the identification and resolution of performance and interpersonal issues among our team.  Monitored and reported any instances of non-compliance with Stanford, stateor federal policies surrounding clinical research amongst junior staff.  Coached junior staff in resolving any issues surrounding the execution of their individual studies.  Facilitated CRA group discussions in evaluation of potentialCRA candidates throughout interview process.  Analyzed technical and communication skills of all CRA candidates, and provide recommendations for hiring. Clinical Research Assistant, Stanford University department of Pediatric Hematology/Oncology; Stanford, CA- July 2011 – August 2012  Coordinated Phase I through IV clinical trials in pediatric oncology.  Contributed in thepre-audit preparation of research material and audit process of our successful 2012 Children’s Oncology Group audit.  Organized and implemented routine internal audits of eligibility and data quality.  Analyzed internal audit findings to recommend improvements in our internal processes.  Designed, and managed, internal database to supervise group progress for quarterly data deadlines.  Developed and coordinated an internal process to execute the ATHN hematological database.  Contributed to routine DataSafety Monitoring Committee audits of research protocols within the Cancer Center.  Prepared for, and participated in site selection visits, siteinitiation visits, routine sponsor monitoring visits, and study close out visits. Clinical ResearchCoordinator, UCSF Multiple Sclerosis Center; San Francisco, CA — July 2010- July 2011  Coordinated and implemented the sound research of phasethree clinical trials specializing in the treatment of Multiple Sclerosis.  Oversaw scheduling of on and off-site study procedures for upwards of thirty study participants.  Managed multiple clinical trials from various sponsors and ensure the sound conduct of all research procedures.  Prepared for and scheduled monthly sponsored monitoring visits.
  • 3.  Maintained numerous aspects of phasethree trials including: investigational drug storage and management, proper storage and maintenance of study participant data, and tracking study participant compliancewithin protocol guidelines. EDUCATION  University Of Illinois at Urbana Champaign, BS Molecular Biology, 2007 Awards and Recognition  Recipient of the 2015 Gilead Clinical Operation Innovation Award for the automation of clinical operations deliverables for Clinical Study Reports.  Recipient of May 2015 Oncology Star Award  Recipient of peer to peer G-Thanks Award for onboarding colleague outside of my immediate team  Recipient of Values at Work Award 2015 SKILLS Database creation and design using the Redcap systemfor clinical research Creating visual reference sheets that help to simplify more complex processes within clinical research Proficient in medical terminology (including oncology) Proficiency in Microsoft office suite Maintaining HIPPA regulatory documents Laboratory maintenance and inventory Research specimen management Obtaining informed consent from study patients Trial drug dispensation, accountability, storage CERTIFICATIONS Data management for clinical researcher statement of accomplishment (Vanderbilt University) Principles of Good Clinical Research certificate of completion Oncology Research Forum certificate of completion CITI Certification BSL Level 2 REFERENCES Available upon request